HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sodium phosphate

This article was originally published in The Tan Sheet

Executive Summary

Physicians should measure baseline, post-treatment levels of electrolytes, creatinine in patients directed to take more than 45 mL oral sodium phosphate within 24 hours "to avert serious electrolyte problems," according to FDA backgrounder posted on CDER Web site Oct. 12. Report discusses data gleaned from medical literature, AER and Drug Quality Reporting System databases, implicating bowel cleanser/laxative in serious electrolyte disturbances. FDA recently announced its intention to limit oral sodium phosphate packages to 45 mL or less (1"The Tan Sheet" Aug. 6, p. 8)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS131416

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel